These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6217454)

  • 1. Relapse of Escherichia coli meningitis following therapy with moxalactam.
    Broughton RA; Mason EO; Baker CJ
    Pediatr Infect Dis; 1982; 1(1):24-8. PubMed ID: 6217454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
    Kumar A; Aziz MT
    Drug Intell Clin Pharm; 1981 Jan; 15(1):50-1. PubMed ID: 6456138
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA; Hoeprich PD; Nolan SM; Goldstein E
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
    McCracken GH; Schaad UB
    Rev Infect Dis; 1982; 4 Suppl():S603-5. PubMed ID: 6218571
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Cherubin CC; Gombert M; Cleri D
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
    Schaad UB; Grimm LM; Beskid G; Cleeland R; Nelson JD; McCracken GH
    Infection; 1982; 10(2):90-6. PubMed ID: 6284652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    Antimicrob Agents Chemother; 1980 Mar; 17(3):406-11. PubMed ID: 6448576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrobacter meningitis and cerebral abscess in early infancy: cure by moxalactam.
    Levy RL; Saunders RL
    Neurology; 1981 Dec; 31(12):1575-7. PubMed ID: 6458777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
    Fisher JF; Carter MJ; Parsons J; Rissing JP
    Antimicrob Agents Chemother; 1981 Feb; 19(2):218-21. PubMed ID: 6214985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 14. Gram-negative bacillary meningitis. New therapy and changing concepts.
    Landesman SH; Cherubin CE; Corrado ML
    Arch Intern Med; 1982 May; 142(5):939-40. PubMed ID: 6211153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs for enteric gram-negative bacillary meningitis in adults.
    Med Lett Drugs Ther; 1981 Aug; 23(17):73-4. PubMed ID: 6267438
    [No Abstract]   [Full Text] [Related]  

  • 18. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W; Pegram PS; McCall CE
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Barriere SL; Wilson CB; Pons VG
    Neurosurgery; 1982 Jun; 10(6 Pt 1):762-5. PubMed ID: 6213879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.